Wallace Akerley

6.7k citations
26 papers · 1.1k · 1 hit paper · h-index 11

Impact in

  • Oncology top 5%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers
    • Peptidase Inhibition and Analysis
    • Lung Cancer Treatments and Mutations
    • Brain Metastases and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 11
    • Lung Cancer Diagnosis and Treatment 4
    • Brain Metastases and Treatment 4
    • Lung Cancer Research Studies 4
    • Cancer Treatment and Pharmacology 3
    • Colorectal Cancer Treatments and Studies 2

Wallace Akerley

26 papers receiving 1.0k citations

Wallace Akerley's Hit Papers

Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer 2016 · 401 citations
4010+3+6Years since publication100200300400

Peers

Wallace Akerley
Comparison fields: 5 of 87
  • Oncology 582
  • Pulmonary and Respiratory Medicine 331
  • Health Informatics 11
  • Genetics 72
  • Epidemiology 186
Replace Jesus Vera Aguilera with:
Jesus Vera Aguilera United States
Rami Manochakian United States
Dipesh Uprety United States
Jacob J. Adashek United States
David Watkins United Kingdom
Stefania Morganti Italy
Ruth Vera Spain
Jonathan Siegel United States
Saoirse Dolly United Kingdom
Amy Tiersten United States
Wallace Akerley relative to Jesus Vera Aguilera United States Jesus Vera Aguilera's profile →
Citations per field
00.5×8.1×
Jesus Vera Aguilera · 1×
Citations per year

Countries citing papers authored by Wallace Akerley

Since Specialization
Citations

This map shows the geographic impact of Wallace Akerley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wallace Akerley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wallace Akerley more than expected).

Fields of papers citing papers by Wallace Akerley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wallace Akerley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wallace Akerley. The network helps show where Wallace Akerley may publish in the future.

Co-authors

The 25 scholars most cited alongside Wallace Akerley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wallace Akerley Line = papers co-authored together Wallace Akerley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer
Hit paper breakdown →
2016401
2 1995131
3 2006129
4 2021114
5 1998102
6 201229
7 201326
8 202023
9
Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
199921
10
Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
199615
11
Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV).
199915
12 199910
13 20028
14 20227
15
Paclitaxel, carboplatin and radiation therapy for non-small-cell lung cancer.
19987
16 20186
17 20005
18 20234
19 20243
20 20073

About Wallace Akerley

Wallace Akerley is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Hepatology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Research Studies (4 papers), Brain Metastases and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Genomics and Diagnostics (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Oncology (582 citations), Pulmonary and Respiratory Medicine (331 citations), Health Informatics (11 citations), Genetics (72 citations) and Epidemiology (186 citations). Wallace Akerley has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Michael Glantz, H. Choy, Kazuhiko Nakagawa, Justin Fairchild, Martin Reck, Libor Havel, Enriqueta Felip, Aleksandra Szczęsna, Paul Lorigan and Michael J. Thomas. Their work appears in journals such as Journal of Clinical Oncology, Cancer, The Journal of Urology, Clinical Lung Cancer and JNCI Journal of the National Cancer Institute.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact